Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 307
Dvorak, V, Casiraghi, A, Colas, C, Koren, A, Tomek, T, Offensperger, F, Rukavina, A, Tin, G, Hahn, E, Dobner, S, Frommelt, F, Boeszoermenyi, A, Bernada, V, Hannich, JT, Ecker, GF, Winter, GE, Kubicek, S & Superti-Furga, G 2023, 'Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors', Cell Chemical Biology, vol. 30, no. 8, pp. 953-964.e9. https://doi.org/10.1016/j.chembiol.2023.06.029

Activities

Leveraging integrated life science data – the power of workflows

Gerhard Ecker
255th ACS National Meeting and Exhibition
Conference, Talk or oral contribution
19.3.2018 - 19.3.2018

Triangulation of repurposing candidates for orphan diseases

Jana Gurinova , Gerhard Ecker , Daniela Digles
Nicht angegeben
Other, Poster presentation
19.3.2018 - 19.3.2018

In silico Toxicology - from prediction of transporter interaction profiles to toxicological read across and beyond

Gerhard Ecker
Frontiers in Medicinal Chemistry
Conference, Talk or oral contribution
13.3.2018 - 13.3.2018

Linking open data - from transporter interaction profiles to toxicity prediction

Gerhard Ecker
In Silico IVIVE
Seminar/Workshop, Talk or oral contribution
20.9.2017 - 20.9.2017

Predicting drug residence time - its all about how long you stay

Gerhard Ecker
Vienna Summer School on Drug Design 2017
Summer/Winter school, Talk or oral contribution
18.9.2017 - 18.9.2017